TOMM20 and cancer: Survivin is overexpressed in cancer cells and its import into the mitochondria is mediated by the AIP–Tom20 complex; this pathway may be a potential target for cancer cells (102), provided that the AIP–survivin interaction can be specifically targeted, as AIP has been shown to bind other mitochondrial pre-proteins (100).